Neuroblastoma: biology, prognosis, and treatment
- PMID: 18242317
- DOI: 10.1016/j.pcl.2007.10.014
Neuroblastoma: biology, prognosis, and treatment
Abstract
Neuroblastoma, a neoplasm of the sympathetic nervous system, is the second most common extracranial malignant tumor of childhood and the most common solid tumor of infancy. Neuroblastoma is a heterogeneous malignancy with prognosis ranging from near uniform survival to high risk for fatal demise. Neuroblastoma serves as a paradigm for the prognostic utility of biologic and clinical data and the potential to tailor therapy for patient cohorts at low, intermediate, and high risk for recurrence. This article summarizes our understanding of neuroblastoma biology and prognostic features and discusses their impact on current and proposed risk stratification schemas, risk-based therapeutic approaches, and the development of novel therapies for patients at high risk for failure.
Similar articles
-
Neuroblastoma: biology, prognosis, and treatment.Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86. doi: 10.1016/j.hoc.2009.11.011. Hematol Oncol Clin North Am. 2010. PMID: 20113896 Review.
-
[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].Arch Pediatr. 2004 Jul;11(7):834-42. doi: 10.1016/j.arcped.2004.02.022. Arch Pediatr. 2004. PMID: 15234382 Review. French.
-
Neuroblastoma in the very young child: biological considerations.Br J Cancer Suppl. 1992 Aug;18:S102-5. Br J Cancer Suppl. 1992. PMID: 1503919 Free PMC article. Review.
-
Neuroblastoma imaging.Rofo. 2011 Mar;183(3):217-25. doi: 10.1055/s-0029-1245903. Epub 2010 Dec 17. Rofo. 2011. PMID: 21170823 Review.
-
Neuroblastoma: biology and therapy.Oncology (Williston Park). 1997 Dec;11(12):1857-66; discussion 1869-72, 1875. Oncology (Williston Park). 1997. PMID: 9436190 Review.
Cited by
-
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.Pediatr Blood Cancer. 2020 Aug;67(8):e28319. doi: 10.1002/pbc.28319. Epub 2020 Jun 15. Pediatr Blood Cancer. 2020. PMID: 32543116 Free PMC article.
-
FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.Mol Biol Cell. 2012 Jun;23(11):2226-34. doi: 10.1091/mbc.E11-06-0535. Epub 2012 Apr 4. Mol Biol Cell. 2012. PMID: 22493319 Free PMC article.
-
Functional genomics identifies therapeutic targets for MYC-driven cancer.Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9545-50. doi: 10.1073/pnas.1121119109. Epub 2012 May 23. Proc Natl Acad Sci U S A. 2012. PMID: 22623531 Free PMC article.
-
Anti-cancer activity of quercetin in neuroblastoma: an in vitro approach.Neurol Sci. 2014 Feb;35(2):163-70. doi: 10.1007/s10072-013-1462-1. Epub 2013 Jun 16. Neurol Sci. 2014. PMID: 23771516
-
Imaging neuroblastoma: what the radiologist needs to know.Cancer Imaging. 2011 Oct 3;11 Spec No A(1A):S44-7. doi: 10.1102/1470-7330.2011.9008. Cancer Imaging. 2011. PMID: 22187096 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical